Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDillistone Regulatory News (DSG)

Share Price Information for Dillistone (DSG)

Share Price is delayed by 15 minutes
Get Live Data
11.50    0.00 (0.00%)
Bid:
11.00
Ask:
12.00
Spread: 1.00 (9.091%)
Market Cap: £4.07m
DSG Live PriceLast checked at - London Stock Exchange

Intraday Dillistone Share Chart

Trading update and Fund Raising

23 Aug 2024 07:00

RNS Number : 4880B
Dillistone Group PLC
23 August 2024
 

23 August 2024

Dillistone Group Plc

("Dillistone", the "Company" or the "Group")

Trading update and Fund Raising

 

Dillistone Group PLC, the AIM quoted supplier of software for the international recruitment industry, provides a trading update and is pleased to announce that it has agreed to raise GBP300,000 through the issue of convertible loan notes ("Loan Notes") and £60,000 through the issue of new ordinary shares (the "New Ordinary Shares") (together the "Fund Raising").

 

The Group announced, on 12 June 2024, that its market remained challenging and, if anything, had softened further in the second quarter. This softness has continued into the third quarter.

 

Today, however, the Group is pleased to confirm that the results for the six months ended 30 June 2024 are likely to be in line with management expectations, which would equate to a significant improvement in operational profitability, compared to the first half in the previous year. The business was again operationally cash generative in the period.

 

The Board considers the Fund Raising to be a prudent course of action in case the Group's markets continue to be challenging for an extended period. The proceeds from the issue of the Loan Notes and the New Ordinary Shares will therefore be used to provide the Group with additional working capital.

 

The Loan Notes, which will be drawn down fully in one tranche when required by the Company, will be provided by Mike Love, the former Chairman of Dillistone, and each of the current Directors (together "Noteholders") of the Company as follows:

 

Giles Fearnley

£60,000

Jason Starr

£90,000

Ian Mackin

£30,000

Steven Hammond

£15,000

Paul Mather

£15,000

Simon Warburton

£15,000

Julie Pomeroy

£5,000

Mike Love

£70,000

 

The Loan Notes carry an interest coupon of 9.85 per cent pa over their maximum term of 48 months, with a conversion price of 14.0 pence per new Dillistone ordinary share, representing a premium over the current price of 55.6%. Interest will be payable quarterly in arrears and will be satisfied in cash. Various rights are built into the agreement for early repayment or conversion.

 

The issue of the Loan Notes to the Directors constitutes a related party transaction under AIM Rule 13. As each of the Directors is participating in the Loan Notes and therefore there is no independent Director for this purpose, Zeus Capital Limited, the Company's nominated advisor, considers that the terms of the Loan Notes are fair and reasonable in so far as Dillistone shareholders are concerned.

 

The 750,000 New Ordinary Shares are being subscribed at 8 pence each by a new independent shareholder. The New Ordinary Shares will, when issued, be credited as fully paid and will rank pari passu in all respects with existing ordinary shares, including the right to receive all dividends and other distributions declared, made or paid after their date of issue. It is expected that admission of these shares to trading on AIM will take place on 29 August 2024.

 

Following Admission, the total number of Ordinary Shares in the capital of the Company in issue will be 20,418,021 with voting rights. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company's share capital pursuant to the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

 

 

Giles Fearnley, Chairman of Dillistone Group Plc, commented: "In a challenging climate, we are pleased that we expect to report positive results in H1. This additional cash injection, supported by every current Board member along with our former Chairman, Dr Mike Love, and a new, independent shareholder shows our confidence in the business. It provides working capital to support trading and will also facilitate the release of significant product updates that we expect to see later in the year.

 

"As and when the recruitment industry recovers, the Group will be well positioned to take advantage."

 

 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

The person responsible for arranging the release of this announcement on behalf of the Company is Ian Mackin, Finance Director of the Company.

 

 

Enquiries:

Dillistone Group Plc

 

Giles Fearnley

Chairman

Via Walbrook PR

 

Jason Starr

Chief Executive Officer

 

Ian Mackin

Finance Director

 

 

Zeus Capital Limited (Nominated adviser)

Chris Fielding

Director, Investment Banking

020 3829 5000

 

 

Walbrook PR

 

Tom Cooper / Joe Walker

Dillistone@walbrookpr.com

 

020 7933 8780

 

0797 122 1972

 

 

Notes to Editors:

Dillistone Group Plc is a leader in the supply and support of software and services to the recruitment industry. Dillistone operates through the Ikiru People (www.IkiruPeople.com) brand.

 

The Group develops, markets and supports the Talentis, FileFinder, Infinity, Mid-Office, ISV and GatedTalent products.

 

Dillistone was admitted to AIM, a market operated by the London Stock Exchange plc, in June 2006.

 

Learn about our products:

Talentis Software: https://www.talentis.global/recruitment-software/

Voyager Software: https://www.voyagersoftware.com

GatedTalent Services: https://www.talentis.global/optimization-services/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQKBBKABKDQFB
Date   Source Headline
7th May 20267:00 amRNSFinal Results & Investor Presentation
24th Apr 20267:00 amRNSNotice of Final Results & Investor Presentation
9th Mar 20262:44 pmRNSHolding(s) in Company
9th Mar 20262:44 pmRNSHolding(s) in Company
9th Mar 20262:23 pmRNSHolding(s) in Company
9th Mar 20262:23 pmRNSHolding(s) in Company
2nd Mar 20263:08 pmRNSHolding(s) in Company
25th Feb 202611:40 amRNSHolding(s) in Company
25th Feb 202610:09 amRNSHolding(s) in Company
23rd Feb 20262:28 pmRNSResult of GM & Directorate Change
11th Feb 202612:59 pmRNSHolding(s) in Company
5th Feb 202611:28 amRNSResult of Placing and Subscription
4th Feb 20264:47 pmRNSProposed Placing and Subscription
30th Sep 20257:00 amRNSInterim Results & Investor Presentation
11th Sep 20257:00 amRNSNotice of Interim Results & Investor Presentation
4th Jun 202511:50 amRNSResult of AGM
4th Jun 20257:01 amRNSAGM Statement
4th Jun 20257:00 amRNSRelated party loan
9th May 202511:32 amRNSDirectorate Declaration
8th Apr 20257:00 amRNSFinal Results & Investor Presentation
3rd Apr 20257:00 amRNSNotice of Results & Investor Presentation
5th Feb 20257:00 amRNSTrading Update & Notice of Results
4th Dec 20247:00 amRNS-ROpenAI powered Interview Simulation Platform
17th Sep 20247:00 amRNSInterim Results & Investor Presentation
11th Sep 20247:00 amRNSNotice of Results & Investor Presentation
2nd Sep 20249:45 amRNSHolding(s) in Company
29th Aug 20248:30 amRNSHolding(s) in Company
23rd Aug 20247:00 amRNSTrading update and Fund Raising
15th Jul 20247:00 amRNSChange of Adviser
12th Jun 20241:40 pmRNSResult of AGM
12th Jun 20247:00 amRNSAGM Statement
25th Apr 20247:00 amRNSFinal Results & Investor Presentation
22nd Apr 20247:00 amRNSNotice of Results & Investor Presentation
9th Apr 20247:00 amRNSBlock listing Interim Review
30th Jan 20247:00 amRNSTrading Update & Notice of Results
9th Oct 20237:00 amRNSBlock listing Interim Review
26th Sep 20237:00 amRNSInterim Results & Investor Presentations
18th Sep 20237:00 amRNSNotice of Results & Investor Presentations
13th Jun 20231:18 pmRNSResult of AGM
13th Jun 20237:00 amRNSAGM Statement
25th Apr 20237:00 amRNSFinal Results & Investor Presentation
11th Apr 20237:00 amRNSBlock listing Interim Review
30th Mar 20237:00 amRNSContract & Notice of Results
2nd Feb 20237:00 amRNSTrading Update & Notice of Results
7th Nov 20227:00 amRNSDirector Dealings
10th Oct 20227:00 amRNSBlock listing Interim Review
26th Sep 20227:01 amRNSDirectorate Changes
26th Sep 20227:00 amRNSInterim Results & Investor Presentation
20th Sep 20227:00 amRNSNotice of Results & Investor Presentation
16th Jun 20228:00 amRNSIssue of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.